Lipoprotein management in patients with cardiometabolic risk

被引：444

作者：

Brunzell, John D. ^{[1
,8
]}

Davidson, Michael ^{[2
]}

Furberg, Curt D. ^{[3
]}

Goldberg, Ronald B. ^{[4
]}

Howard, Barbara V. ^{[5
]}

Stein, James H. ^{[6
]}

Witztum, Joseph L. ^{[7
]}

机构：

[1] Univ Washington, NW Lipid Lab, Seattle, WA 98195 USA

[2] Univ Chicago Pritzker, Sch Med, Chicago, IL USA

[3] Wake Forest Univ, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA

[4] Univ Miami, Dept Med, Div Endocrinol, Miami, FL 33152 USA

[5] MedStar Res Inst, Hyattsville, MD USA

[6] Univ Wisconsin, Sch Med & Publ Hlth, Div Cardiovasc Med, Dept Med, Madison, WI USA

[7] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA

[8] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA

来源：

DIABETES CARE | 2008年 / 31卷 / 04期

关键词：

D O I：

10.2337/dc08-9018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：811 / 822

页数：12

共 92 条

[1] The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent [J].

Ala-Korpela, Mika ;

Lankinen, Niko ;

Salminen, Aino ;

Suna, Teemu ;

Soininen, Pasi ;

Laatikainen, Reino ;

Ingman, Petri ;

Jauhiainen, Matti ;

Taskinen, Marja-Riitta ;

Heberger, Karoly ;

Kaski, Kimmo .

ATHEROSCLEROSIS, 2007, 190 (02) :352-358

[2] Standards of medical care in diabetes 2008 [J].

不详 .

DIABETES CARE, 2008, 31 :S12-S54

[3]

ANGELIN B, 1978, J LIPID RES, V19, P1017

[4]

[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360

[5] Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring effective reductions in cholesterol using rosuvastatin therapY (MERCURY) II [J].

Ballantyne, Christie M. ;

Bertolami, Marcelo ;

Garcia, Rugo Ricardo Hernandez ;

Nul, Daniel ;

Stein, Evan A. ;

Theroux, Pierre ;

Weiss, Robert ;

Cain, Valerie A. ;

Raichlen, Joel S. .

AMERICAN HEART JOURNAL, 2006, 151 (05) :975.e1-975.e9

[6] Effects of torcetrapib in patients at high risk for coronary events [J].

Barter, Philip J. ;

Caulfield, Mark ;

Eriksson, Mats ;

Grundy, Scott M. ;

Kastelein, John J. P. ;

Komajda, Michel ;

Lopez-Sendon, Jose ;

Mosca, Lori ;

Tardif, Jean-Claude ;

Waters, David D. ;

Shear, Charles L. ;

Revkin, James H. ;

Buhr, Kevin A. ;

Fisher, Marian R. ;

Tall, Alan R. ;

Brewer, Bryan .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122

[7] Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel [J].

Barter, PJ ;

Ballantyne, CM ;

Carmena, R ;

Cabezas, MC ;

Chapman, MJ ;

Couture, P ;

De Graaf, J ;

Durrington, PN ;

Faergeman, O ;

Frohlich, J ;

Furberg, CD ;

Gagne, C ;

Haffner, SM ;

Humphries, SE ;

Jungner, I ;

Krauss, RM ;

Kwiterovich, P ;

Marcovina, S ;

Packard, CJ ;

Pearson, TA ;

Reddy, KS ;

Rosenson, R ;

Sarrafzadegan, N ;

Sniderman, AD ;

Stalenhoef, AF ;

Stein, E ;

Talmud, PJ ;

Tonkin, AM ;

Walldius, G ;

Williams, KMS .

JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) :247-258

[8] Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women [J].

Blake, GJ ;

Otvos, JD ;

Rifai, N ;

Ridker, PM .

CIRCULATION, 2002, 106 (15) :1930-1937

[9] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].

BLANKENHORN, DH ;

NESSIM, SA ;

JOHNSON, RL ;

SANMARCO, ME ;

AZEN, SP ;

CASHINHEMPHILL, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240

[10] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

← 1 2 3 4 5 6 7 8 9 10 →